Francisco Silva's most recent trade in BioRestorative Therapies Inc was a trade of 768,979 Stock Option done . Disclosure was reported to the exchange on Feb. 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 768,979 | 768,979 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 08 Apr 2024 | 6,600 | 155,759 | - | 1.3 | 8,250 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 1.17 per share. | 08 Apr 2024 | 1,232 | 149,159 | - | 1.2 | 1,441 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 08 Apr 2024 | 476 | 147,927 | - | 1.1 | 538 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 18 Mar 2024 | 17,193 | 147,451 | - | 1.4 | 23,898 | Common Stock |
| BioRestorative Therapies Inc | Silva Francisco | Director, VP of Research and Development, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 394,737 | 394,737 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 31 Aug 2023 | 4,954 | 164,644 | - | 2.2 | 10,998 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 3.56 per share. | 31 Mar 2023 | 747 | 159,690 | - | 3.6 | 2,659 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.92 per share. | 20 Mar 2023 | 6,729 | 158,943 | - | 2.9 | 19,649 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 18 Feb 2023 | 374 | 165,672 | - | 3.0 | 1,118 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 106,762 | 106,762 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 2.62 per share. | 21 Nov 2022 | 943 | 166,046 | - | 2.6 | 2,467 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 293,479 | 293,479 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Nov 2022 | 293,479 | 0 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2022 | 42,059 | 42,059 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Nov 2022 | 42,059 | 0 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 3.39 per share. | 12 Oct 2022 | 725 | 165,103 | - | 3.4 | 2,457 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 3.69 per share. | 11 Oct 2022 | 806 | 164,378 | - | 3.7 | 2,973 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Sale of securities on an exchange or to another person at price $ 3.39 per share. | 26 Aug 2022 | 3,958 | 158,156 | - | 3.4 | 13,410 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 3.21 per share. | 26 Aug 2022 | 2,816 | 163,572 | - | 3.2 | 9,048 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 3.35 per share. | 26 Aug 2022 | 2,600 | 160,756 | - | 3.4 | 8,710 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 3.32 per share. | 26 Aug 2022 | 307 | 12,136 | - | 3.3 | 1,019 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 3.78 per share. | 14 Jun 2022 | 263 | 162,114 | - | 3.8 | 993 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 4.65 per share. | 07 Jun 2022 | 565 | 161,851 | - | 4.6 | 2,627 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2022 | 12,438 | 161,286 | - | - | Common Stock | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 6.66 per share. | 19 Nov 2021 | 4,000 | 11,829 | - | 6.7 | 26,626 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 6.62 per share. | 16 Nov 2021 | 4,000 | 7,829 | - | 6.6 | 26,500 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Purchase of securities on an exchange or from another person at price $ 6.83 per share. | 16 Nov 2021 | 3,826 | 3,829 | - | 6.8 | 26,132 | Common Stock |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Nov 2021 | 293,479 | 0 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 293,479 | 293,479 | - | - | Stock Option | |
| BioRestorative Therapies Inc | Francisco Silva | Director, VP of Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Nov 2021 | 42,059 | 42,059 | - | - | Stock Option |